The Vanguard Group 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Voyager Therapeutics, Inc. VYGR |
The Vanguard Group | 2,529,668 5.750% |
574,496 (+29.38%) |
Filing |
| 2023-02-09 11:37 am Sale |
2022-12-30 | 13G | Voyager Therapeutics, Inc. VYGR |
The Vanguard Group | 1,955,172 5.060% |
-116,873 (-5.64%) |
Filing |
| 2022-02-10 08:42 am Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
The Vanguard Group | 2,072,045 5.460% |
-345,606 (-14.30%) |
Filing |
| 2021-02-10 12:00 pm Purchase |
2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
The Vanguard Group | 2,417,651 6.450% |
324,603 (+15.51%) |
Filing |